Takayasu's arteritis, also called TAK, is a rare form of vasculitis disease involving inflammation in the walls of the largest arteries in the body: the aorta and its main branches. The disease results from an attack by the body's own immune system, causing inflammation in the walls of arteries.
Takayasu's arteritis is occasionally called “pulseless disease”, because of the difficulty in detecting peripheral pulses that sometimes occurs as a result of the vascular narrowings.
Takayasu arteritis is a rare disorder characterized by the progressive inflammation of one or more of the larger arteries leading from the heart. The main artery of the heart (aorta) and the pulmonary (lung) artery, among others, may be affected.
AdvertisementBlood tests. These tests can be used to look for signs of inflammation. ... X-rays of your blood vessels (angiography). ... Magnetic resonance angiography (MRA). ... Computerized tomography (CT) angiography. ... Ultrasonography. ... Positron emission tomography (PET).
Takayasu arteritis is a rare autoimmune disease. It causes redness and swelling (inflammation) of the large arteries. It's a rare disease that's much more common in young women. It is also believed to be more common in people from East Asia, India, and South America.
Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic vasculitides with predominantly granulomatous infiltrates that affect the aorta and its main branches. GCA and TAK comprise the group of large-vessel vasculitides. Traditionally, they are considered two different clinical entities.
A prognostic score for death and vascular complications was elaborated based on a multivariate model. Results: Among 318 TA patients, 16 (5%) died after a median [IQR] follow-up of 6.1 [2.8-13.0] years. The median age at death was 38 [25-47] years with 88% of women.
Although there is no cure for Takayasu's arteritis, it is a treatable disease. Most people who have it improve with treatment. However, for many people, TAK can be partially, or less often, completely disabling. The effects of illness on function may be significant.
The most well-recognized genetic susceptibility locus for the disease is the classical HLA allele, HLA-B*52, which has been confirmed in several ethnicities. The genetic susceptibility with HLA-B*52, as well as additional classical alleles and loci, implicate both HLA class I and class II involvement in TAK.
Takayasu arteritis, also known as pulseless disease, occlusive thromboaortopathy, and Martorell syndrome,1 is a chronic inflammatory arteritis affecting large vessels, predominantly the aorta and its main branches. Vessel inflammation leads to wall thickening, fibrosis, stenosis, and thrombus formation.
Takayasu withdrew from the September 2021 tournament with a hip injury after he was driven out of the ring by yokozuna Terunofuji in their Day 11 contest.
Takayasu arteritis can be life-threatening by an occlusion of the ascending aorta and its major branches, without any coronary arteries involvement.
With Takayasu's arteritis, the aorta and other major arteries, including those leading to your head and kidneys, can become inflamed. Over time the inflammation causes changes in these arteries, including thickening, narrowing and scarring.
Takayasu's disease (also known as "aortic arch syndrome", "nonspecific aortoarteritis" and the "pulseless disease":841) is a form of large vessel granulomatous vasculitis with massive intimal fibrosis and vascular narrowing, affecting often young or middle-aged women of Asian descent.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 446.7 was previously used, M31.4 is the appropriate modern ICD10 code.
446.7 is a legacy non-billable code used to specify a medical diagnosis of takayasu's disease. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
References found for the code 446.7 in the Index of Diseases and Injuries:
Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown.
General Equivalence Map Definitions The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.